And CharlieBulls post #75018224, which discusses Bell Potter's estimate of share value if a 'trade sale' was to occur:
"....our reasonable estimate of Enterprise value in a trade sale is ~US$3bn today (EV A$4.7bn after adjusting for cash) ie A$15/Share
01/08/2024.
"Being a biotechnology stock carrying significant risk biotechnology risk, our valuation is limited to 100% upside from the current market price. Revised valuation is $10/share and we retain our Buy (Speculative) rating."
The Bear Room, page-44
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.20 |
Change
0.190(2.71%) |
Mkt cap ! $2.305B | |||
| Open | High | Low | Value | Volume |
| $7.12 | $7.34 | $6.95 | $5.698M | 788.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 16776 | $7.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.27 | 197 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |